Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Protein drink tested for Post-Workout recovery in healthy adults

NCT ID NCT07497113

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a commercially available high-protein yoghurt drink helps muscles recover after intense exercise. 62 healthy adults aged 18-45 took part. Researchers measured amino acid levels in the blood and markers of muscle damage, inflammation, and physical function over 72 hours. The goal was to see if the drink improves recovery compared to a plain protein drink or flavored water.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-protein yoghurt drink
What this could lead to
If the results show benefits, it could support using this drink to help muscle recovery after exercise.
What could go wrong
This is a small, completed study in healthy people, so findings may not apply to athletes or those with medical conditions. The drink is not a treatment for any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

62 people

The number who actually took part.

Started

Mar 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 and ≤ 45 years. * Body Mass Index (BMI) ≥ 18.5 and ≤ 29.9 kg/m2 (measured at the first assessment), * Written informed consent (undertaken at the first assessment). * Willingness and ability to comply with the protocol in the opinion of the investigator. * Judged by the investigator to be in good health as assessed by a health screening questionnaire. * Currently identifies as the same biological sex as at birth. Exclusion Criteria: * Any known ongoing medical condition that might interfere with absorption and digestion and/or gastrointestinal (GI) function (e.g. inflammatory bowel disease, gastroesophageal reflux disease, celiac disease, diaphragmatic hernia or diaphragmatic surgery, gastric ulcer, gastritis, gall bladder problems, pancreatitis, GI cancer, oesophageal and/or gastric surgery).), in opinion of the investigator, * Known musculoskeletal or soft tissue injury. * Known cardiovascular disease, disease related to the immune system and/or the respiratory system. * Known renal or hepatic failure or known thyroid dysfunction. * Known Diabetes Mellitus type I or type II, insulin resistance or metabolic syndrome. * Any ongoing cancer (except for basal cell carcinoma) and/ or cancer treatment, * Known anaemia or low haemoglobin or low iron status. * Any known bleeding disorder or reaction to withdrawal of blood samples. * Use of oral and systemic use of prokinetics, laxatives, antidiarrheals, anticoagulants within 2 weeks prior to screening. * Use of systemic antibiotics within 4 weeks prior to screening. * Any known dietary allergies. * Any known intolerances to ingredients of the study product, i.e. dairy, cow's milk allergies, lactose intolerance. * Self-reported adherence to a strict dietary regime (e.g. vegetarian/ vegan/ paleo/ketogenic/intermittent fasting/ high protein diet (\>1.6 g/kg body weight/day), or protein supplementation or a weight loss program, as confirmed via the screening process. * Use of any nutritional supplements or additional protein supplements or nutritional support within 4 weeks prior to screening. * Engage (on average) in more than 2 resistance exercise sessions and/or more than 4 exercise sessions in total weekly within 2 months before screening, * Considered as endurance trained, competitive athletes or trained weightlifters, powerlifters or bodybuilders, in the opinion of the investigator. * Known pregnancy and/or lactating. * Current smoking or stopped smoking for \<1 month prior to screening (except for incidental smoking of ≤3 cigarettes/cigars/pipes per week on average in the last month). * Average alcohol use of \>21 glasses\* per week for men or \>14 glasses per week for women (on average during the last 6 months) or drug/ medicine abuse in opinion of the investigator. * Participation in any other clinical study with investigational or marketed products concomitantly or within 4 weeks before screening. * Major medical or surgical event requiring hospitalization within the preceding 3 months and/or scheduled in the period of study participation relevant in the opinion of the investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy participants are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Anglia Ruskin University

    Cambridge, RH14 9YY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.